🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/2015 13,84 14,09 13,23 13,49 -2,95% 6,21% 870.800
27/02/2015 13,42 14,00 13,12 13,90 +0,58% 6,56% 1.295.700
26/02/2015 14,39 14,67 13,58 13,82 -7,81% 7,57% 1.465.700
25/02/2015 14,68 15,36 14,56 14,99 +1,22% 5,45% 1.182.800
24/02/2015 15,49 15,68 14,38 14,81 -4,39% 8,39% 1.215.800
23/02/2015 15,23 15,74 14,60 15,49 +1,84% 7,49% 1.381.500
20/02/2015 15,23 15,44 15,17 15,21 +0,20% 1,77% 596.800
19/02/2015 14,68 15,45 14,60 15,18 +3,27% 5,79% 868.000
18/02/2015 14,66 14,84 14,29 14,70 +0,07% 3,75% 695.400
17/02/2015 13,58 14,76 13,58 14,69 +15,13% 8,69% 2.819.400
13/02/2015 12,70 12,87 12,52 12,76 +0,87% 2,76% 445.700
12/02/2015 12,45 12,85 12,32 12,65 +2,26% 4,26% 416.500
11/02/2015 12,54 13,00 12,27 12,37 -1,67% 5,82% 575.300
10/02/2015 12,42 12,62 12,13 12,58 +2,03% 3,95% 348.400
09/02/2015 12,30 12,84 12,26 12,33 -0,48% 4,72% 580.900
06/02/2015 12,87 13,03 12,32 12,39 -3,65% 5,52% 558.400
05/02/2015 12,24 12,91 12,24 12,86 +3,71% 5,47% 735.000
04/02/2015 12,11 12,50 11,97 12,40 +1,31% 4,38% 538.300
03/02/2015 11,91 12,25 11,53 12,24 +2,94% 6,05% 711.200
02/02/2015 12,02 12,18 11,55 11,89 -0,92% 5,24% 738.800
30/01/2015 12,19 12,54 12,00 12,00 -2,44% 4,43% 524.100
29/01/2015 12,00 12,30 11,85 12,30 +2,50% 3,75% 483.000
28/01/2015 12,41 12,41 11,90 12,00 -2,60% 4,11% 622.900
27/01/2015 12,44 12,59 12,03 12,32 -0,96% 4,50% 509.500
26/01/2015 12,21 12,54 12,01 12,44 +2,13% 4,34% 666.400
23/01/2015 12,19 12,34 11,97 12,18 -0,33% 3,04% 610.900
22/01/2015 11,96 12,30 11,52 12,22 +3,12% 6,52% 738.800
21/01/2015 11,74 12,05 11,51 11,85 +0,68% 4,60% 707.800
20/01/2015 12,13 12,22 11,42 11,77 -2,81% 6,60% 810.600
16/01/2015 11,81 12,19 11,73 12,11 +2,02% 3,90% 702.000